These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 4393395)
1. [The mechanisms of increased vascular permeability in tumor tissues: isolation and purification of permeability factors and their physico-chemical and biological properties]. Nishimura K Kumamoto Igakkai Zasshi; 1970 Apr; 44(4):298-318. PubMed ID: 4393395 [No Abstract] [Full Text] [Related]
4. The isolation and purification of a chemotaxis-promoting factor for cancer cells (carinoegresin) from cancerous tissues and its physico-chemical properties. Yoshida K Kumamoto Med J; 1970 Mar; 23(1):1-13. PubMed ID: 4320051 [No Abstract] [Full Text] [Related]
5. Difference in electrokinetic charge of cells between two cell types of ascites hepatoma after removal of sialic acid. Kojima K; Maekawa A Cancer Res; 1970 Dec; 30(12):2858-62. PubMed ID: 4321973 [No Abstract] [Full Text] [Related]
6. Effect of endotoxin from Serratia marcescens on the permeability of vessels in hepatomas and carrageenin granulomas of rats. Oswald NT; Cater DB Br J Exp Pathol; 1969 Feb; 50(1):84-96. PubMed ID: 4304259 [No Abstract] [Full Text] [Related]
8. The vascular endothelial growth factor receptor KDR/Flk-1 is a major regulator of malignant ascites formation in the mouse hepatocellular carcinoma model. Yoshiji H; Kuriyama S; Hicklin DJ; Huber J; Yoshii J; Ikenaka Y; Noguchi R; Nakatani T; Tsujinoue H; Fukui H Hepatology; 2001 Apr; 33(4):841-7. PubMed ID: 11283848 [TBL] [Abstract][Full Text] [Related]
9. Failure of histamine type mediators to enhance vascular permeability in experimental liver metastases. Ackerman NB; Hechmer PA; Makohon S Surg Gynecol Obstet; 1980 Nov; 151(5):647-51. PubMed ID: 6159691 [TBL] [Abstract][Full Text] [Related]
10. NTP Toxicology and Carcinogenesis Studies of Methyleugenol (CAS NO. 93-15-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 2000 Jul; 491():1-412. PubMed ID: 12563349 [TBL] [Abstract][Full Text] [Related]
11. [Studies to the effect of drugs on the plasmalymph-barrier of rats after the estabolshment of a condition of increased capillary permeability]. Vogel G; Wendt B; Ströcker H Arzneimittelforschung; 1967 Apr; 17(4):454-8. PubMed ID: 4386770 [No Abstract] [Full Text] [Related]
13. [Effects of cadmium on the testis and its vascular permeability]. Maekawa K; Tsunenari Y; Kurematsu Y Kaibogaku Zasshi; 1966 Dec; 41(6):327-33. PubMed ID: 4382756 [No Abstract] [Full Text] [Related]
14. Enzymic processes in vascular permeability and fragility changes in the skin radiation reaction. Jolles B; Harrison RG Bibl Anat; 1967; 9():482-7. PubMed ID: 4382113 [No Abstract] [Full Text] [Related]
15. [Effect of interventional chemothermotherapy on vascular permeability of tumor liver tissue and normal liver tissue in VX-2 tumor-bearing rabbits]. Liu Y; Zhang HX; Cao XM; Liu YY; Li WX; Ni DH; Cao W Ai Zheng; 2002 Sep; 21(9):954-6. PubMed ID: 12508540 [TBL] [Abstract][Full Text] [Related]
16. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent. Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995 [TBL] [Abstract][Full Text] [Related]
17. Differences in vascular permeability between normal and tumor vessels produced by vasoactive agents. Ackerman NB Surg Forum; 1973; 24():105-7. PubMed ID: 4805958 [No Abstract] [Full Text] [Related]
18. Vascular distribution of experimental hepatomas. Matsumura H Nihon Geka Hokan; 1965 Jul; 34(4):974-96. PubMed ID: 4283954 [No Abstract] [Full Text] [Related]
19. The effect of anti-inflammatory drugs on increased vascular permeability induced by chemical mediators. Carr J J Pathol; 1972 Sep; 108(1):1-14. PubMed ID: 4405410 [No Abstract] [Full Text] [Related]
20. Expression of urocortin in rat lung and its effect on pulmonary vascular permeability. Wu Y; Xu Y; Zhou H; Tao J; Li S J Endocrinol; 2006 Apr; 189(1):167-78. PubMed ID: 16614391 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]